Expert Q&A: Vaccine Quality Control in Analytical Methods and Emerging Technologies

As vaccine technologies continue to evolve, from cutting-edge mRNA platforms to viral vectors and protein subunits, so must the strategies used to ensure their safety, efficacy, and consistency.
 

In this expert Q&A, Dr Arnaud Delobel of Quality Assistance shares insights into the analytical foundations of vaccine quality control. He discusses the tools used to characterize complex formulations, how to validate methods for novel modalities, and where the field is headed next.